Accessibility Menu
 
Orgenesis logo

Orgenesis

(OTC) ORGS

Current Price$0.25
Market Cap$1.29M
Since IPO (2010)-34%
5 Year-100%
1 Year-90%
1 Month+67%

Orgenesis Financials at a Glance

Market Cap

$1.29M

Revenue (TTM)

$12.87M

Net Income (TTM)

$43.94M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

232.61 (High)

Price

$0.25

Volume

100

Open

$0.25

Previous Close

$0.25

Daily Range

$0.25 - $0.25

52-Week Range

$0.00 - $4.00

ORGS News

No articles available.

ORGS: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Orgenesis

Industry

Biotechnology

Employees

146

CEO

Vered Caplan

Headquarters

Germantown, MD 20876, US

ORGS Financials

Key Financial Metrics (TTM)

Gross Margin

-11%

Operating Margin

-101%

Net Income Margin

-104%

Return on Equity

0%

Return on Capital

29%

Return on Assets

-4%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.29M

Shares Outstanding

5.17M

Volume

100

Short Interest

0.00%

Avg. Volume

962.016

Financials (TTM)

Gross Profit

$5.72M

Operating Income

$53.64M

EBITDA

$60.72M

Operating Cash Flow

$14.84M

Capital Expenditure

$2.10M

Free Cash Flow

$16.93M

Cash & ST Invst.

$837.00K

Total Debt

$22.62M

Orgenesis Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2024YOY CHG

Revenue

$347.00K

+215.5%

Gross Profit

$238.00K

-720.7%

Gross Margin

-68.59%

N/A

Market Cap

$1.29M

N/A

Market Cap/Employee

$8.85K

N/A

Employees

146

N/A

Net Income

$9.12M

+344.8%

EBITDA

$7.66M

-203.0%

Quarterly Fundamentals

Name
Q3 2024YOY CHG

Net Cash

$17.09M

+21.2%

Accounts Receivable

$1.40M

+24.4%

Inventory

$0.00

-100.0%

Long Term Debt

$10.10M

-45.5%

Short Term Debt

$7.19M

+124.3%

Return on Assets

-3.80%

N/A

Return on Invested Capital

28.91%

N/A

Free Cash Flow

$4.69M

-216.5%

Operating Cash Flow

$4.63M

-292.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
UNBXUnity Biotechnology, Inc.
$0.06+0.00%
EMMAEmmaus Life Sciences, Inc.
$0.01+0.76%
SQZBSQZ Biotechnologies Company
$0.02-0.41%
NGMCNext Generation Management Corp.
$2.10+90.91%

Trending Stocks

Symbol / CompanyPricePrice Chg
CMCSAComcast
$29.02+0.00%
INTCIntel
$43.87-0.05%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.08-0.06%
RITMRithm Capital
$8.77-0.03%

Questions About ORGS

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.